ChinaPLAGH
ChinaPLAGH
Beijing, Haidian, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma | Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, extranodal nasal NK/T cell lymphoma, lymphoma, neoplasm | Recruiting | Phase 2 | 2023-04-27 | NCT05833893 |